Ceftorque T 1.125 combines Ceftriaxone and Tazobactam to treat bacterial infections including respiratory tract infections, intra-abdominal infections, urinary tract infections, septicemia, and meningitis.
Route of Administration
Intravenous (IV) / Intramuscular (IM)
Composition
Each vial contains:
- Ceftriaxone Sodium (Sterile) eq. to Anhydrous Ceftriaxone I.P. 1000 mg
- Tazobactam Sodium (Sterile) eq. to Anhydrous Tazobactam I.P. 125 mg
Indications
Ceftorque T 1.125 Dry Injection is indicated for the treatment of bacterial infections, including respiratory tract infections, intra-abdominal infections, urinary tract infections, septicemia, and meningitis caused by susceptible microorganisms.
Storage
Store protected from light and moisture at a temperature not exceeding 25°C.
Precautions
Use only under the supervision of a qualified healthcare professional. Consult your physician before use if you have a history of allergy to cephalosporins, penicillins, or other beta-lactam antibiotics. Caution is advised in patients with kidney or liver disorders. Complete the prescribed course of treatment and do not discontinue therapy without medical advice.
Presentation
12 × 20 × 1.125 g glass vial.
